Helius Medical Technologies
Open
$2.06
Prev. Close
$2.06
High
$2.06
Low
$2.05
Market Snapshot
$81.78M
-2.0
-4304.65
$520K
21
Solana Co. is a neurotech company in the medical device industry that focuses on neurological wellness. The company is headquartered in Newtown, Pennsylvania and currently employs 21 full-time employees. The company went IPO on 2014-06-27. The company is focused on maximizing SOL per share by leveraging capital markets opportunities and on chain activity. The company offers public market investors optimal exposure to Solana’s secular growth. The company has adopted a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises that produce consistent on-chain yield generation. The company will provide access to the Solana network. Solana DAT provides access to the blockchain market to a new kind of investor. As a global capital markets onramp, HSDT channels liquidity into the Solana ecosystem, strengthening network security and fueling on chain activity, creating a virtuous cycle that delivers value back to shareholders.
emptyResult
Solana Co. is a neurotech company in the medical device industry that focuses on neurological wellness. The company is headquartered in Newtown, Pennsylvania and currently employs 21 full-time employees. The company went IPO on 2014-06-27. The company is focused on maximizing SOL per share by leveraging capital markets opportunities and on chain activity. The company offers public market investors optimal exposure to Solana’s secular growth. The company has adopted a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises that produce consistent on-chain yield generation. The company will provide access to the Solana network. Solana DAT provides access to the blockchain market to a new kind of investor. As a global capital markets onramp, HSDT channels liquidity into the Solana ecosystem, strengthening network security and fueling on chain activity, creating a virtuous cycle that delivers value back to shareholders.
Recently from Cashu
Helius Medical Technologies Prepares for Key Earnings Report on Neuromodulation Innovations
Helius Medical Technologies: Pioneering Neuromodulation Therapies Helius Medical Technologies, a company focused on innovative therapies for neurological conditions, prepares to release its quarterly…
Helius Medical Technologies: Upcoming Earnings Report on PoNS and Neuromodulation Innovations
Helius Medical Technologies: Advancements in Neuromodulation Therapies Helius Medical Technologies is poised to release its quarterly earnings report on November 18, 2025, a critical juncture as the c…
Helius Medical Technologies Prepares for Earnings Report Spotlighting PoNS Innovations and Future Growth
Helius Medical Technologies Prepares for Key Earnings Report Amid Innovative Developments Helius Medical Technologies is on the verge of releasing its quarterly earnings report on November 18, 2025, a…
Helius Medical Technologies: Key Updates and Future Outlook for Stock Investors
Please provide the text you would like summarized, and I’ll be happy to help!